Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Am J Transplant. 2016 May 17;16(10):2903–2911. doi: 10.1111/ajt.13820

Figure 2 (two panels).

Figure 2 (two panels)

Figure 2 (two panels)

  1. a: Unadjusted patient survival of patients with end-stage liver disease in HealthCore and Medicaid, stratified by waitlisting and transplant status
    1. Figure legend
      graphic file with name nihms776803f4.jpg
    2. Risk table
      Years since ESLD diagnosis
      0 1 2 3 4 5
      Healthcore; never listed 15,045 7,992 5,014 3,199 1,985 1,196
      Medicaid; never listed 61,303 28,148 19,476 13,507 9,017 5,590
      HealthCore; listed, not transplanted 897 747 544 393 294 200
      Medicaid; listed, not transplanted 3,615 2,214 1,581 1,100 711 438
      HealthCore; listed, transplanted 882 829 722 624 493 395
      Medicaid; listed, transplanted 2,788 2,149 1,706 1,312 924 588
  2. b: Unadjusted patient survival of patients with end-stage liver disease in HealthCore with a calculated MELD score ≥15
    1. Figure legend
      graphic file with name nihms776803f5.jpg
    2. Risk table
      Years since ESLD diagnosis
      0 1 2 3 4 5
      Never listed 949 496 321 216 162 108
      Listed, not transplanted 128 81 56 38 23 12
      Listed, transplanted 125 105 84 71 57 44